For that, adiponectin is considered a protective factor against pathological processes such as peripheral insulin resistance and cardiovascular diseases, whereas low levels of adiponectin in obesity contributes to chronic inflammation and obesity-associated risk for related diseases (For recent reviews, see Ohashi et al., 2015; Liu et al., 2016). This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.